Safety of prolonged wait time for gastrectomy in clinical stage I gastric cancer

European Journal of Surgical Oncology

Volumn 45, Issue 10, 2019, Pages 1964-1968

  Fujiya, Keiichi ^a   Irino, Tomoyuki ^a,b   Furukawa, Kenichiro ^a   Omori, Hayato ^a   Makuuchi, Rie ^a   Tanizawa, Yutaka ^a   Bando, Etsuro ^a   Terashima, Masanori ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Comorbidity; Elderly; Endoscopy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTRECTOMY; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURGICAL APPROACH; SURGICAL TECHNIQUE; TIME TO TREATMENT; TREATMENT OUTCOME; EPIDEMIOLOGY; FOLLOW UP; JAPAN; MIDDLE AGED; PROCEDURES; STOMACH TUMOR; SURVIVAL RATE; TIME FACTOR;

AGED; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 85067422849     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2019.06.006     Document Type: Article

References (23)

1. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg 2011;253:779-785.
2. Richards MA, Westcombe AM, Love SB, Littlejohns P and Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353:1119-1126.
3. Simunovic M, Rempel E, Theriault M-E, Baxter N, Virnig B, Meropol N, et al Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival. Can J Surg 2009;52:E79-E86.
4. Khanderia E, Markar S, Acharya A, Kim Y-W and Hanna G. The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival: A Meta-Analysis of Comparative Studies in the Far East. J Clin Gastroenterol 2016;50:190-197.
5. Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon Ferguson J, et al Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015;112 Suppl 1:S92-107.
6. Comber H, Cronin DP, Deady S, Lorcain PO and Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J 2005;98:238-239.
7. Raptis D, Fessas C, Belasyse Smith P and Kurzawinski T. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. The surgeon 2010;8:239-246.
8. Brazda A, Estroff J, Euhus D, Leitch AM, Huth J, Andrews V, et al Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol 2010;17 Suppl 3:291-296.
9. Furukawa K, Irino T, Makuuchi R, Koseki Y, Nakamura K, Waki Y, et al Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer. Gastric Cancer 2018; Epub ahead of print.
10. Sobin LH, Gospodarowicz MK and Wittekind C. TNM classification of malignant tumours, Seventh Edition. New York: Wiley-Blackwell; 2010.
11. Japanese Gastric Cancer A. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112.
12. Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19.
13. Kawamura T, Makuuchi R, Tokunaga M, Tanizawa Y, Bando E, Yasui H, et al Long-term outcomes of gastric cancer patients with preoperative sarcopenia. Ann Surg Oncol 2018;25:1625-1632.
14. Haugstvedt TK, Viste A, Eide GE and Soreide O. Patient and physician treatment delay in patients with stomach cancer in Norway: is it important? The Norwegian Stomach Cancer Trial. Scand J Gastroenterol 1991;26:611-619.
15. Sharpe D, Williams RN, Ubhi SS, Sutton CD and Bowrey DJ. The “two-week wait” referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer. Eur J Surg Oncol 2010;36:977-981.
16. Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 2012;23:2731-2737.
17. Rapoport Y, Kreitler S, Chaitchik S, Algor R and Weissler K. Psychosocial problems in head-and-neck cancer patients and their change with time since diagnosis. Ann Oncol 1993;4:69-73.
18. Windham TC, Termuhlen P, Ajani J and Mansfield P. Adenocarcinoma of the stomach in patients age 35 years and younger: no impact of early diagnosis on survival outcome. J Surg Oncol 2002;81:118-124. discussion 24.
19. Fernandez E, Porta M, Malats N, Belloc J and Gallen M. Symptom-to-diagnosis interval and survival in cancers of the digestive tract. Dig Dis Sci 2002;47:2434-2440.
20. Ziliotto A, Jr., Kunzle JE, De Souza A and Colicchio-Filho O. Evolutive and prognostic aspects in gastric cancer. Analysis of 189 cases. Cancer 1987;59:811-817.
21. Maconi G, Kurihara H, Panizzo V, Russo A, Cristaldi M, Marrelli D, et al Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol 2003;38:1249-1255.
22. Honda M, Hiki N, Kinoshita T, Yabusaki H, Abe T, Nunobe S, et al. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Ann Surg 2016;264:214-222.
23. Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, et al Survival rates in T1 and T2 gastric cancer: A Western report. J Surg Oncol 2016;114:602-606.